GlaxoSmithKline Consumer Healthcare Ltd. posted a net profit of ₹132 crore for the quarter ended December 2015, up 37 per cent from ₹96.41 crore in the corresponding quarter the previous year. The company said gross sales grew 7 per cent to ₹1,100 crore for the period. In a statement, Manoj Kumar, Managing Director, GlaxoSmithKline Consumer Healthcare, said: “Our core differentiator remains our science and we will strengthen our focus to constantly innovate. Today our products continue to be available at affordable price points.” Our Bureau
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.